Verition Fund Management
XLRN

Verition Fund Management’s Acceleron Pharma XLRN Stock Holding History

Verition Fund Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,716
Closed -$295K – 2995
2021
Q3 		$295K Buy
+1,716
New +$224K ﹤0.01% 1476

Verition Fund Management's XLRN Position: Q4 2021 in Review

Verition Fund Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,716 shares — an estimated $295K sold.

Verition Fund Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $295K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Verition Fund Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Verition Fund Management sold 1,716 Acceleron Pharma shares in Q4 2021, an estimated $295K.
  • Verition Fund Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Verition Fund Management's Acceleron Pharma position peaked at $295K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Verition Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.